EVENTIDE ASSET MANAGEMENT, LLC - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Nektar Therapeutics (NKTR)

Filing Manager
EVENTIDE ASSET MANAGEMENT, LLC
Reporting Manager
Eventide Asset Management, LLC
Security
Nektar Therapeutics Common Stock, $0.0001 par value
Symbol
NKTR
Shares outstanding
184M shares
Disclosed Ownership
6.65M shares
Ownership
3.61%
Form type
SCHEDULE 13G/A
Date filed
2/14/2025, 12:08 PM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Eventide Asset Management, LLC 3.61% 6.65M 6.65M 0 /s/ Peter J. Luiso Peter J. Luiso, General Counsel
Finny Kuruvilla, M.D., Ph. D. 3.61% 6.65M 0 6.65M /s/ Finny Kuruvilla, M.D., Ph. D. Finny Kuruvilla, M.D., Ph. D.
Robin C. John 3.61% 6.65M 0 6.65M /s/ Robin C. John Robin C. John